Prognostic significance of p53 immunohistochemistry for p53 mutated tumors

被引：0
|
作者：
Wurl, P
Dralle, H
Taubert, H
Meye, A
Berger, D
Schmidt, H
Holzhausen, HJ
Rath, FW
机构：
[1] UNIV HALLE WITTENBERG,CLIN GEN SURG,HALLE,GERMANY
[2] UNIV HALLE WITTENBERG,INST PATHOL,HALLE,GERMANY
来源：
EUROPEAN JOURNAL OF CELL BIOLOGY | 1997年 / 72卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [31] p53 β-hydroxybutyrylation attenuates p53 activity
    Kun Liu
    Fangzhou Li
    Qianqian Sun
    Ning Lin
    Haichao Han
    Kaiqiang You
    Feng Tian
    Zebin Mao
    Tingting Li
    Tanjun Tong
    Meiyu Geng
    Yingming Zhao
    Wei Gu
    Wenhui Zhao
    Cell Death & Disease, 10
  • [32] p53 β-hydroxybutyrylation attenuates p53 activity
    Liu, Kun
    Li, Fangzhou
    Sun, Qianqian
    Lin, Ning
    Han, Haichao
    You, Kaiqiang
    Tian, Feng
    Mao, Zebin
    Li, Tingting
    Tong, Tanjun
    Geng, Meiyu
    Zhao, Yingming
    Gu, Wei
    Zhao, Wenhui
    CELL DEATH & DISEASE, 2019, 10 (3)
  • [33] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    Hofstetter, G.
    Berger, A.
    Fiegl, H.
    Slade, N.
    Zoric, A.
    Holzer, B.
    Schuster, E.
    Mobus, V. J.
    Reimer, D.
    Daxenbichler, G.
    Marth, C.
    Zeimet, A. G.
    Concin, N.
    Zeillinger, R.
    ONCOGENE, 2010, 29 (13) : 1997 - 2004
  • [34] Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer
    Kaserer, K
    Schmaus, J
    Bethge, U
    Migschitz, B
    Fasching, S
    Walch, A
    Herbst, F
    Teleky, B
    Wrba, F
    JOURNAL OF PATHOLOGY, 2000, 190 (04): : 450 - 456
  • [35] The prognostic significance of ataxia-telangiectasia-mutated (ATM) and p53 expression in breast cancer
    Suh, K. J.
    Ryu, H. S.
    Lee, K-H
    Im, S-A
    Kim, T-Y
    Kim, H.
    Yang, Y.
    Moon, H-G
    Han, S-W
    Oh, D-Y
    Han, W.
    Kim, T-Y
    Park, I. A.
    Noh, D-Y
    Bang, Y-J
    CANCER RESEARCH, 2016, 76
  • [36] p53 isoforms change p53 paradigm
    Bourdon, J. C.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (04):
  • [37] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    G Hofstetter
    A Berger
    H Fiegl
    N Slade
    A Zorić
    B Holzer
    E Schuster
    V J Mobus
    D Reimer
    G Daxenbichler
    C Marth
    A G Zeimet
    N Concin
    R Zeillinger
    Oncogene, 2010, 29 : 1997 - 2004
  • [38] Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma
    Li, Wenbin
    Guo, Lei
    Bi, Xingang
    Ma, Jianhui
    Zheng, Shan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9446 - 9451
  • [39] P53 alterations in colon tumors - A comparison of SSCP/sequencing and immunohistochemistry
    Curtin, K
    Slattery, ML
    Holubkov, R
    Edwards, S
    Holden, JA
    Samowitz, WS
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (04): : 380 - 386
  • [40] MUTATIONS AND IMMUNOHISTOCHEMISTRY OF P53 AND PROLIFERATION MARKERS IN ASTROCYTIC TUMORS OF CHILDHOOD
    SCHIFFER, D
    CAVALLA, P
    DISAPIO, A
    GIORDANA, MT
    MAURO, A
    CHILDS NERVOUS SYSTEM, 1995, 11 (09) : 517 - 522
12345